Figures & data
Figure 2 Axial A) and coronal B) contrast-enhanced fat-suppressed T1-weighted MR images showing bilateral eyelid, lateral rectus oculomotor, masticatory and temporal muscle enlargement and enhancement.
![Figure 2 Axial A) and coronal B) contrast-enhanced fat-suppressed T1-weighted MR images showing bilateral eyelid, lateral rectus oculomotor, masticatory and temporal muscle enlargement and enhancement.](/cms/asset/02cdeb4a-d269-44be-bfe8-a4974f0b2584/doph_a_9369_f0002_b.jpg)
Figure 3 Diffuse infiltrate rich in lymphocytes, foamy histiocytes, and giant cells (hematoxylin and eosin: x250). A) Giant cells of Touton type, B) nodular lymphoid infiltrate.
![Figure 3 Diffuse infiltrate rich in lymphocytes, foamy histiocytes, and giant cells (hematoxylin and eosin: x250). A) Giant cells of Touton type, B) nodular lymphoid infiltrate.](/cms/asset/423f2136-0ac2-4f73-8870-c1dcfcbe73c2/doph_a_9369_f0003_c.jpg)
Figure 4 Six months of treatment. Significant regression of eyelid swelling (A, B). Follow-up MRI: axial (C) and coronal (D) contrast-enhanced fat-suppressed T1-weighted MR images shows normalization of eyelid, lateral rectus oculomotor, masticatory and temporal muscle.
![Figure 4 Six months of treatment. Significant regression of eyelid swelling (A, B). Follow-up MRI: axial (C) and coronal (D) contrast-enhanced fat-suppressed T1-weighted MR images shows normalization of eyelid, lateral rectus oculomotor, masticatory and temporal muscle.](/cms/asset/0085c5e2-f36c-4f98-802a-0e8d5ec6a798/doph_a_9369_f0004_c.jpg)